Flexible Etherified and Esterified Triphenylethylene Derivatives and Their Evaluation on ER Positive and Triple Negative Breast Cancer Cell Lines

Tamoxifen (TAM) is a selective estrogen receptor modulator with potential clinical benefits for all stages of breast cancer. Investigators reported novel TAM analogues that could avoid metabolism via CYP2D6.